{"id":"https://openalex.org/W4361908578","doi":"https://doi.org/10.1158/1078-0432.22451084.v1","title":"Supplementary Table 2 from A Phase I Trial of Dasatinib, an Src-Family Kinase Inhibitor, in Combination with Paclitaxel and Carboplatin in Patients with Advanced or Recurrent Ovarian Cancer","display_name":"Supplementary Table 2 from A Phase I Trial of Dasatinib, an Src-Family Kinase Inhibitor, in Combination with Paclitaxel and Carboplatin in Patients with Advanced or Recurrent Ovarian Cancer","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361908578","doi":"https://doi.org/10.1158/1078-0432.22451084.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22451084.v1","doi":"https://doi.org/10.1158/1078-0432.22451084.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22451084.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_2_from_A_Phase_I_Trial_of_Dasatinib_an_Src-Family_Kinase_Inhibitor_in_Combination_with_Paclitaxel_and_Carboplatin_in_Patients_with_Advanced_or_Recurrent_Ovarian_Cancer/22451084/1/files/39902171.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_2_from_A_Phase_I_Trial_of_Dasatinib_an_Src-Family_Kinase_Inhibitor_in_Combination_with_Paclitaxel_and_Carboplatin_in_Patients_with_Advanced_or_Recurrent_Ovarian_Cancer/22451084/1/files/39902171.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062151371","display_name":"Angeles Alvarez Secord","orcid":"https://orcid.org/0000-0003-0946-7662","observed_orcids":["https://orcid.org/0000-0003-0946-7662"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angeles Alvarez Secord","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110082461","display_name":"Deanna K. Teoh","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Deanna K. Teoh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112035683","display_name":"William Thomas Barry","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William T. Barry","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073319456","display_name":"Miao Yu","orcid":"https://orcid.org/0000-0002-2804-6014","observed_orcids":["https://orcid.org/0000-0002-2804-6014","https://orcid.org/0000-0002-9080-5931"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Miao Yu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111691313","display_name":"Gloria Broadwater","orcid":"https://orcid.org/0000-0002-9845-7564","observed_orcids":["https://orcid.org/0000-0002-9845-7564"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gloria Broadwater","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085606987","display_name":"Laura Jean Havrilesky","orcid":"https://orcid.org/0000-0002-4259-5992","observed_orcids":["https://orcid.org/0000-0002-4259-5992"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura J. Havrilesky","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023802024","display_name":"Paula S. Lee","orcid":"https://orcid.org/0000-0003-3524-0058","observed_orcids":["https://orcid.org/0000-0003-3524-0058"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paula S. Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038248146","display_name":"Andrew Berchuck","orcid":"https://orcid.org/0000-0002-1940-1467","observed_orcids":["https://orcid.org/0000-0002-1940-1467"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Berchuck","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045131302","display_name":"Johnathan M. Lancaster","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johnathan Lancaster","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5044655732","display_name":"Robert Michael Wenham","orcid":"https://orcid.org/0000-0002-6156-8885","observed_orcids":["https://orcid.org/0000-0002-6156-8885"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert M. Wenham","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":1.0},{"id":"https://openalex.org/keywords/src-family-kinase-inhibitor","display_name":"Src family kinase inhibitor","score":0.9620000123977661},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":1.0},{"id":"https://openalex.org/keywords/advanced-ovarian-cancer","display_name":"advanced ovarian cancer","score":0.8040000200271606},{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":1.0},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.7429999709129333}],"concepts":[{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.8998403549194336},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.8254522085189819},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.750939130783081},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6342570781707764},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6238042116165161},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5951256155967712},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5576759576797485},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5192325711250305},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.47752490639686584},{"id":"https://openalex.org/C108636557","wikidata":"https://www.wikidata.org/wiki/Q21109354","display_name":"Proto-oncogene tyrosine-protein kinase Src","level":3,"score":0.4334806799888611},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.347942054271698},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2518877387046814},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.09564006328582764},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07773301005363464},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.06677117943763733}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.22451084.v1","doi":"https://doi.org/10.1158/1078-0432.22451084.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22451084.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_2_from_A_Phase_I_Trial_of_Dasatinib_an_Src-Family_Kinase_Inhibitor_in_Combination_with_Paclitaxel_and_Carboplatin_in_Patients_with_Advanced_or_Recurrent_Ovarian_Cancer/22451084/1/files/39902171.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22451084","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_2_from_A_Phase_I_Trial_of_Dasatinib_an_Src-Family_Kinase_Inhibitor_in_Combination_with_Paclitaxel_and_Carboplatin_in_Patients_with_Advanced_or_Recurrent_Ovarian_Cancer/22451084","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22451084.v1","doi":"https://doi.org/10.1158/1078-0432.22451084.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22451084.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_2_from_A_Phase_I_Trial_of_Dasatinib_an_Src-Family_Kinase_Inhibitor_in_Combination_with_Paclitaxel_and_Carboplatin_in_Patients_with_Advanced_or_Recurrent_Ovarian_Cancer/22451084/1/files/39902171.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6100000143051147}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361908578.pdf","grobid_xml":"https://content.openalex.org/works/W4361908578.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4244439098","https://openalex.org/W2417982295","https://openalex.org/W2007753220","https://openalex.org/W2329492928","https://openalex.org/W2003594160","https://openalex.org/W3143032809","https://openalex.org/W3093965993","https://openalex.org/W1224191223","https://openalex.org/W1981117703","https://openalex.org/W2143807312"],"abstract_inverted_index":{"PDF":[0],"file,":[1],"50K,":[2],"Response":[3],"in":[4],"each":[5],"dosing":[6],"cohort.":[7]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2025-10-10T00:00:00"}